|
Volumn 30, Issue 5, 2007, Pages 375-378
|
Widespread hyoscine hydrobromide toxicity due to contract manufacturer malpractice: The Travacalm episode
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DONNALIX;
HYOSCYAMINE;
SCOPOLAMINE;
SPASMOLYTIC AGENT;
TRAVACALM;
UNCLASSIFIED DRUG;
ABNORMAL BEHAVIOR;
AGITATION;
AMNESIA;
ANXIETY;
AUDITORY HALLUCINATION;
AUSTRALIA;
BLURRED VISION;
CONFUSION;
DISORIENTATION;
DIZZINESS;
DRUG INDUCED DISEASE;
DRUG MANUFACTURE;
DRUG SURVEILLANCE PROGRAM;
DYSARTHRIA;
FATIGUE;
GAIT DISORDER;
HUMAN;
INSOMNIA;
MALPRACTICE;
MUSCLE WEAKNESS;
PRIORITY JOURNAL;
REVIEW;
SIDE EFFECT;
SPEECH DISORDER;
STOMACH DISCOMFORT;
URINE RETENTION;
VISUAL HALLUCINATION;
XEROSTOMIA;
ADULT;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
AUSTRALIA;
CHILD;
CONTRACTS;
DRUG AND NARCOTIC CONTROL;
DRUG INDUSTRY;
FEMALE;
HUMANS;
MALE;
MALPRACTICE;
MIDDLE AGED;
MOTION SICKNESS;
SCOPOLAMINE;
TABLETS;
|
EID: 34248365963
PISSN: 01145916
EISSN: None
Source Type: Journal
DOI: 10.2165/00002018-200730050-00002 Document Type: Review |
Times cited : (6)
|
References (11)
|